Home / business / Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

-
Relief Therapeutics' chairman said he was optimistic its RLF100 (aviptadil) drug will win approval for treating COVID19 patients in a matter of months.

from Top Business News- News18.com
Read The Rest:timesnownews...
Relief Therapeutics sees 60-70% chance of COVID-19 drug approval Relief Therapeutics sees 60-70% chance of COVID-19 drug approval Reviewed by Team Exprssnews on August 08, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.